Andreas Sellmer

HDAC1 and HDAC2 integrate the expression of p53 mutants in pancreatic cancer

Nataša Stojanović, Zonera Hassan, Matthias Wirth et al. · Oncogene · 2016 · 104 citations

Oncology, Pancreatic Cancer, Medicine +8

Novel Chimeric Histone Deacetylase Inhibitors: A Series of Lapatinib Hybrides as Potent Inhibitors of Epidermal Growth Factor Receptor (EGFR), Human Epidermal Growth Factor Receptor 2 (HER2), and Histone Deacetylase Activity

Siavosh Mahboobi, Andreas Sellmer, Mathias Winkler et al. · Journal of Medicinal Chemistry · 2010 · 96 citations · Full text

Histone Modifications, Chromatin, Medicine +13

Design of Chimeric Histone Deacetylase- and Tyrosine Kinase-Inhibitors: A Series of Imatinib Hybrides as Potent Inhibitors of Wild-Type and Mutant BCR-ABL, PDGF-Rβ, and Histone Deacetylases

Siavosh Mahboobi, Stefan Dove, Andreas Sellmer et al. · Journal of Medicinal Chemistry · 2009 · 90 citations · Full text

Histone Deacetylases, Hdac Inhibitors, Tumor Biology +17

Marbostat-100 Defines a New Class of Potent and Selective Antiinflammatory and Antirheumatic Histone Deacetylase 6 Inhibitors

Andreas Sellmer, Hubert Stangl, Mandy Beyer et al. · Journal of Medicinal Chemistry · 2018 · 77 citations · Full text

Bis(1<i>H</i>-2-indolyl)methanones as a Novel Class of Inhibitors of the Platelet-Derived Growth Factor Receptor Kinase

Siavosh Mahboobi, Steffen Teller, Herwig Pongratz et al. · Journal of Medicinal Chemistry · 2002 · 76 citations · Full text

Indole Moiety, Pharmacotherapy, Chemical Biology +18